What to read today: 23% of Americans who owe a rent or a mortgage payment on Friday aren't sure if they'll have the money for it. Dow, S&P 500 post best month since 1987. The Fed expands its $600 billion lending program for struggling businesses but leaves start date unannounced. And much more.
A potential vaccine for the novel coronavirus codeveloped by pharmaceutical giant Pfizer and German biotech BioNTech has entered human trials in Germany, and is expected to be tested in the US as early as next week.
The duo's vaccine could be set for emergency use in the fall — well ahead of experts' predictions — with the potential for hundreds of millions of doses to be produced in 2021.
The promise of BioNTech's recent work with Pfizer lies in biotech firms' research brawn and ability to rapidly develop vaccine candidates for novel diseases via technologies like AI.
P.S. Business Insider Intelligence and eMarketer have been tracking the impacts of the coronavirus on technology, marketing, and the digital economy. Read our latest coverage here — and stay safe!
This report explores how the onus of the US' mental health crisis falls on health systems and hospitals, and how they can navigate the costly dilemma via telemental health. We dive into challenges providers are presented with amid the crisis and how traditional mental health strategies are falling short in addressing them.
US consumers are shopping online more as they continue to avoid brick-and-mortar. More than a third of respondents to an eMarketer survey purchased food and beverages online in April 2020, up 9 percentage points from February 2020. Online purchases of pharmaceutical and health products also increased 6 percentage points from February to April.
